Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05135169

Enrollment

Registered

2021-11-26

Start date

2022-03-03

Completion date

2025-06-30

Last updated

2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Interventions

DRUGDefinity Suspension for Injection

Administration of Definity

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* at least 18 years old * able to give informed consent

Exclusion criteria

1. Known allergic reaction to Definity ultrasound contrast 2. Pregnancy/Nursing - as assessed/disclosed by the participant

Design outcomes

Primary

Measure	Time frame	Description
transit time	during procedure	time it takes for contrast to traverse an organ

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026